Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

FDA advisory committee recommends approval of Lucemyra

March 28, 2018

Novel metabotropic glutamate mGlu7 receptor agonists synthesized at Takeda

March 28, 2018

Soligenix receives E.U. orphan designation for RiVax

March 23, 2018

Institute of Radiation Medicine presents novel compounds protecting against radiation

March 19, 2018

Japanese researchers disclose PDE7 inhibitors

March 15, 2018

University of Bristol presents new alpha4beta2 nicotinic receptor partial agonists

March 8, 2018

Anti-heroin vaccine demonstrates efficacy in rodents

March 7, 2018

Sublocade becomes available as first and only monthly injectable buprenorphine in the U.S.

March 2, 2018

NOP agonist AT-312 can reduce alcohol reward

Feb. 26, 2018

Pain Therapeutics resubmits Remoxy ER NDA

Feb. 14, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...